Ignite Creation Date:
2024-05-06 @ 3:08 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04535713
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2020-08-27
Brief Title:
GALLANT Metronomic Gemcitabine Doxorubicin Docetaxel and Nivolumab for Advanced Sarcoma
Sponsor:
Organization:
Sarcoma Oncology Research Center LLC